Leading Stocks: Leading IPO

IPO LEADERS

ATRA [NASD]

Atara Biotherapeutics, Inc.

Healthcare | Biotechnology | USA

Lead Underwriter : Goldman Sach & Citi, IPO 10/16/14
Business Description: Early-stage biotech targeting muscle loss in patients with end-stage renal disease.

Shares Outstanding:	24.36M
Float:	10.13M

Yahoo Finance Key Statistics

Yahoo Finance Analyst Estimates

Streetinsider Earnings Info

Zacks EPS Chart

Price, Consensus and EPS Surprise(Zacks)

Google Finance Revenue, Net income and Profit Margin Chart
CNN Money Financials
CNN Money Forecast

EPS rating: 5, Marketcap 1.03B, Annual Sales=0, ROE -59.2%, EPS %chg last qtr: -20%, Debt 0%,PE N/a.

Long Bias: $40

FIT [NYSE]

Fitbit Inc

Consumer Goods | Electronic Equipment | USA

Lead Underwriter : Morgan Stanley, IPO 6/8/15
Business Description:

Shares Outstanding:	M
Float:	M

Consumer Product-Electronic, EPS rating:78

INCR [NASD]

INC Research Holdings, Inc.

Services | Research Services | USA

Lead Underwriter : Goldman Sachs, IPO 11/7/14

Business Description:

Shares Outstanding:	M
Float:	M

Medical-Research Equipment/Services, EPS rating:82

CHRS [NASD]

Coherus Biosciences, Inc.

Healthcare | Biotechnology | USA
EPS rating:3

MCRB [NASD]

Seres Therapeutics, Inc.

Healthcare | Biotechnology | USA

Goldman Sachs, IPO: 6/26/15,Medical Biotech, EPS rating:2

CYBR [NASD]

CyberArk Software, Ltd.

Technology | Business Software & Services | Israel

Lead Underwriter : J P Morgan, Deutsche Bank, 09/24/14
Business Description: Provides enterprise software that detects cyber attacks on privileged accounts.

Shares Outstanding:	29.58M
Float:	15.33M

Marketcap: 1.9B, EPS rating:99, EPS growth rate 5year 32%, EPS %chg last qtr 1500%, sales %chg last qtr 89%, pretax margin 19.7%, Debt 0%, Earning stability:18, PE:100(5.9xSP), ROE 16%, cash flow $0.54, R&D 14%,

ONCE [NASD]

Spark Therapeutics, Inc.

Healthcare | Biotechnology | USA

Lead Underwriter : J P Morgan, Credit Suisse, IPO 1/30/15
Business Description: Developing gene therapy treatments for orphan retinal dystrophies.

SharesOutstanding:20.6M
Float:	20.14M

marketcap $1.8B, U/D Vol: 0.9, EPS rating:2, Annual sales 1M, EPS %chg lastqtr 122%, sales %chg last qtr 11250%, pretax margin -3827%, Debt 0%, PE N/a, ROE -83%

PFNX [AMEX]

Pfenex Inc.

Healthcare | Biotechnology | USA

Lead Underwriter : William Blair & JMP Securities

Business Description: Developing a biosimilar version of Roche's Lucentis treatment for wet AMD.

Shares Outstanding:	20.52M
Float:	10.34M

NVRO [NYSE]

Nevro Corp.

Healthcare | Medical Appliances & Equipment | USA

Lead Underwriter : J P Morgan, Morgan Stanley

Business Description: Awaiting approval for an implanted electrical device that treats leg and back pain.

Shares Outstanding:	24.88M
Float:	9.65M

DPLO [NYSE]

Diplomat Pharmacy, Inc.

Healthcare | Drugs - Generic | USA

Lead Underwriter : Credit Suisse, Morgan Stanley

Business Description: Operates the fourth largest specialty pharmacy in the US.

Shares Outstanding:	57.00M
Float:	22.72M

SAGE [NASD]

Sage Therapeutics, Inc.

Healthcare | Biotechnology | USA

Lead Underwriter : J P Morgan, Goldman Sachs

Business Description: Developing treatments for life-threatening epileptic seizures.

Shares Outstanding:	25.81M
Float:	8.47M

IRMD [NASD]

IRadimed Corporation

Healthcare | Medical Appliances & Equipment | USA
Underwriter : Roth Capital Partners, Monarch Capital Group
Business Description: Makes non-magnetic MRI-safe IV infusion pumps.

Shares Outstanding:	10.97M
Float:	3.47M

JUNO [NASD]

Juno Therapeutics Inc.

Healthcare | Biotechnology | USA
Lead Underwriter : Morgan Stanley, JP Morgan
Business Description: Developing T-cell therapies for lymphomas, leukemias and other cancers.

Immunotherapy is a form of cancer treatment that uses a patient’s immune system to fight cancer. Juno Therapeutics. ADAP (UK based) is another company working in the Cancer Therapy field.

Shares Outstanding:	90.4M
Float:	43.00M

News:
4/21: Juno Therapeutics Gets Lift From Cancer Test Results

SHAK [NYSE]

Shake Shack Inc.

Services | Specialty Eateries | USA

Lead Underwriter : Morgan Stanley, JP Morgan

Business Description: Fast-casual burger chain with 36 US and 27 international locations.

Shares Outstanding:	12.06M
Float:	5.88M

GRUB [NYSE]

GrubHub Inc.

Technology | Internet Information Providers | USA
Lead Underwriter :Citi, Morgan Stanley
Business Description: Online portal for food delivery service supporting 28,800 restaurants in 600 cities.